Analysis of systematic reviews shows uncertainty about cardiovascular risk in individuals taking risperidone, suggesting a need for better studies.
The available evidence from systematic reviews is of low to very low certainty and indicates substantial uncertainty regarding the cardiovascular effects of risperidone. Higher-quality systematic reviews with improved reporting and methodology are required.
No takes yet. Share an insight, caveat, or question.
Gianini et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: